. IL-1 may be released by activated alveolar macrophages in diseases characterized by pulmonary inflammation. We therefore investigated whether IL-1 is a chemotactic factor for peripheral blood polymorphonuclear cells (PMN) in CF, as PMN and their products appear to contribute to CF lung injury. Heparinized blood was obtained from 9 CF children and 8 normal subjects. PMN were isolated using dextran sedimentation. Using a 48 well microchemotaxis chamber, IL-1 chemotactic activity for PMN was evaluated. A wide range of purified human IL-1 ollaborative Res.) (6 concentrations from 10-12~ to 10-M was used and comared to the powerful chemotactic factor FMLP at B 10-M. RPMI medium was employed as a negative control. IL-1 was chemotactic for PMN from both normals and CF with a peak activity at ~O -~M . The CF PMN showed significantly increased migration compared to normal at and cells per 10 oil immersion fields) (p<0.1 by Mann Whitney U test). A further experiment with CF PMN showed that IL-1 chemotactic activity peaked at ~x~o -~M .
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The CF PMN showed significantly increased migration compared to normal at and cells per 10 oil immersion fields) (p<0.1 by Mann Whitney U test). A further experiment with CF PMN showed that IL-1 chemotactic activity peaked at ~x~o -~M .
CF PMN chemotaxis to FMLP at I O -~M was not significantly different from normal. Further studies are needed to assess the local activity of IL-1 and its ability to attract inflammatory cells to the lungs in CF. 85% were asymptomatic. Hilar adenopathy alone was seen in 116, infiltrates in 56, miliary disease and pleural effusion in 4 each and 5 had cavities. Extrapulmonary disease was seen in 12, 1 1 with cervical adenitis and 1 with arthritis. Patients were monitored and medication dispensed by public health nurses, under the supervision of the aothors. Treatment was with largely twice weekly INH and rifampin for 6 months for cases with hilar adenopathy alone, 9 months for all others. P.espiratory symptoms cleared quick1.y; cervical nodes in 2-7 months. Most roentgenograms were free of infiltrates in less than a year but hilar adenopathy lasted 1-3 years. Two had drug toxicity (vomiting, rash). Therapy was successfully completed in 168, with greater than 2 year follow-up in 116 without relapse. A pediatrician helps assure good care for children in a Health Department Tuberculosis Program. vaccines c o n s i~t i n~o f OS derived from PRP and conjugated by reductive amination to the nontoxic diphtheria mutant toxin CRM 197 (C) were previously shown to elicit memory-type serum anti-PRP responses in human infants. Here we seek to define structural variables that control the infant's response. In the coupled OS, the nonreducing (and hence exposed) terminal group can be ribitol (r), ribose (R), or phosphate (p). A series of rterminal OS of mean length 4, 6, or 12 repeat units were coupled to C at ca. 10 ribose/protein, and OS of 12 repeat units terminating in R or p were coupled at ca. 30 ribose/protein. A 2-injection sequence was given to healthy infants aged 9-15 mo (groups of 8-10). Anti-PRP Ab was assayed by radioantigen binding; at 1 mo after the 2" the geometric means (GM) and 95% confidence intervals (CI) .. --- To dete6jne the usefulness of magnetic resonance (MR) imaging in children with herpesvirus infections affecting the central nervous system (CNS), we obtained MR scans in nine children, ranging in age from two weeks to ten years, who had neurologic disorders caused by members of the herpesvirus group. Clinical syndromes included: neonatal herpes simplex virus (HSV) encephalitis, symptomatic congenital cytomegalovirus (CMV) infection, congenital varicella-zoster virus (VZV) infection, post-VZV encephalopathy, and acute Epstein-Barr virus (EBV) encephalitis. MR scans were abnormal in eight children and demonstrated a wide range of cerebral abnormalities including cystic encephalomalacia, ventricular enlargement, cerebral atrophy, and focal parenchymal lesions. In young infants with severe congenital or perinatal infections due to HSV, CMV, or VZV, the results of MR were comparable to those of computed tomography (CT), although MR was m r e sensitive in defining the extent of the lesions in brain parenchyma. MR in two of these children demonstrated abnormalities of cerebral white matter one to two years after recovery from their neonatal infections. In a child with EBV encephalitis CT was normal, whereas MR revealed bilateral abnormalities that corresponded to the clinical and electroencephalographic findings. In post-VZV encephalopathy,MR detected transient abnormalities of the cerebral and cerebellar peduncles. These results indicate that MR effectively detects abnormalities of the CNS during childhood herpesvirus infections.
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To investigate further the interaction of cytomegalovirus (CMV) with blood leukocytes, we studied the kinetics of leukocyte infection during sublethal murine CMV (MCMV) infection. Three-week old Balb/c mice were infected ip with lo5 plaqueforming-units of MCMV, and mononuclear and granulocyte-enriched leukocyte fractions were studied 0, 1, 3, 5, 7, 14, and 20 days post-infection using in situ nucleic acid hybridization, detection of antiaen by monoclonal antibodies, and culture for -. . -. -. . infectious virus.-By day 3, imnediate-early MCMV antigens were detected in the leukocytes of all infected animals (mean of 200 antigen-posi tive cel ls/lo6 leukocytes). By day 5, antigens, nucleic acid, and infectious virus were detected in the leukocytes of all animals and were present until day 14. By each method, peak infection was observed on day 5. At peak infection, more cells contained antigens (mean of 248 antigen-positive cells/l06 leukocytes) than contained nucleic acid (mean of 6 4 nucleic acid positive cel ls/l06 leukocytes) (p<0.001). On day 5, 73% of the antigen-positive cells were lymphocytes and 23% were monocytes, with MCMV antigens in 0.2 to 0.9% of the lymphocytes harvested from MCMV-infected animals. Infection of leukocytes in these studies corresponded to our previous observations regarding the timing of MCMV-induced alterations in lymphocyte subset numbers and mitogen responsiveness. These studies provide additional support for the concept that CMV-induced imnunosuppression is attributable to direct infection of blood leukocytes. Children initially irmunized with PRP or P F P D conlugate v a c cines bet-15 and 24 mnths of age were assessed 1 year later for persistence of AB and response to revaccination with PRP, PFPD, or normal saline (N=lll). Pre and post-vaccination sera were obtained and anti-PRP antibodies were assayed by RIA. Adverse reactions were minor and noted in <5% of vaccinees. AB levels a year after initial inmunization were significantly higher in subjects inmunized with PRP-D(@l 1.12 ug/d) than with PRP (0.22 ug/ml) (p<.0001). All groups demonstrated an increase in anti-PRP levels after revaccination, although this response was significantly greater in subjects initially i m i z e d with PRP-D, regardless of booster vaccine given. Initial vaccine: P W (N=47) PRP-D (N=64) Booster vaccine: % >1.0 ug/ml 20% 67% 96% 75% 97% 100%
PERSI-
(Not signif .: a=c=e, a=b, g=i=k, g=h, d=f, j=l) (p<.001: d>c, f>e, j>i, l>k, l>f, j>d, j>f, l>d) Children imTunized with PRP or P F P D between 15 to 24 mnths of age respond dramatically to reirnrunization one year later, although children previously immunized with PRP-D show the greatest responses even with conventional PRP antigen.
